Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes
Author(s) -
Iuliia Polina,
Hailey J. Jansen,
Tiesong Li,
Motahareh Moghtadaei,
Loryn J. Bohne,
Yingjie Liu,
Pooja S. Krishnaswamy,
Emmanuel E. Egom,
Darrell D. Belke,
Sara A. Rafferty,
Martin Ezeani,
Anne M. Gillis,
Robert A. Rose
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1914853117
Subject(s) - atrial fibrillation , medicine , type 2 diabetes , cardiology , diabetes mellitus , atrial myocytes , insulin , endocrinology
Significance Atrial fibrillation (AF) is prevalent in diabetic patients, yet the basis for AF in diabetes is poorly understood. We have used type 1 diabetic Akita mice to study the effects of insulin on atrial electrophysiology in diabetes. We demonstrate that Akita mice are highly susceptible to AF due to impaired electrical conduction and that insulin treatment can reduce the occurrence of this arrhythmia. Atrial action potential morphology was altered in Akita mice in association with reductions in atrial Na+ current (INa ) and repolarizing potassium current. Insulin treatment potently increased atrial INa via distinct chronic and acute effects. These experiments identify antiarrhythmic effects of insulin in type 1 diabetes via potent effects on atrial INa .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom